Table 5 Comparison of total cost elements between the "Most costly" COPD patients and the remainder.
From: Determinants of elevated healthcare utilization in patients with COPD
|  | "Most costly"*(n = 98) | The remainder (n = 291) | P value†|
|---|---|---|---|
Annualized Total Cost | 9681 ± 6475 | 1899 ± 1185 | <0.001 |
(US$/person) | 7692 (6365 - 9892) | 1632 (949 - 2660) | Â |
Hospitalization | 4129 ± 3549 | 607 ± 745 | <0.001 |
Annualized Costs ($US/person) | 3147 (1567 - 6061) | 352 (0 - 875) | Â |
Annualized Days/person | 10.4 ± 10.7 | 1.4 ± 1.7 | <0.001 |
| Â | 7.4 (3.6 - 13.8) | 0.8 (0 - 2.0) | Â |
Annualized | 2.4 ± 1.9 | 0.5 ± 0.6 | <0.001 |
Admissions/person | 1.9 (1.0 - 3.0) | 0.2 (0 - 0.6) | Â |
Average Length | 4.3 ± 2.4 | 3.4 ± 2.2 | <0.001 |
Days/Admission | 3.7 (3.0 - 4.9) | 3.0 (2.0 - 4.0) | Â |
Surgeries | 2557 ± 2817 | 268 ± 565 | <0.001 |
Annualized Costs ($US/person) | 1991 (477 - 4166) | 0 (0 - 238) | Â |
Annualized | 0.4 ± 0.3 | 0.1 ± 0.1 | <0.001 |
Number/person | 0.4 (0.2 - 0.6) | 0 (0 - 0.2) | Â |
Diagnostic procedures | 676 ± 444 | 357 ± 264 | <0.001 |
Annualized Costs ($US/person) | 631 (339 - 849) | 289 (161 - 506) | Â |
Annualized | 8.6 ± 4.9 | 5.5 ± 3.4 | <0.001 |
Number/person | 7.4 (5.2 - 12.2) | 4.8 (3.0 - 7.2) | Â |
Consultations | 278 ± 180 | 174 ± 124 | <0.001 |
Annualized Costs ($US/person) | 256 (141 - 381) | 157 (77 - 240) | Â |
Annualized | 9.1 ± 6.0 | 5.7 ± 4.0 | <0.001 |
Visits/person | 8.2 (4.4 - 12.6) | 5.0 (2.4 - 8.0) | Â |
Emergency Room Visit | 108 ± 121 | 40 ± 51 | <0.001 |
Annualized Costs ($US/person) | 59 (29 - 147) | 29 ( 0 - 59) | Â |
Annualized | 0.7 ± 0.8 | 0.3 ± 0.3 | <0.001 |
Visits/person | 0.4 (0.2 - 1.0) | 0.2 (0 - 0.4) | Â |
Medication | 1856 ± 5855 | 432 ± 327 | <0.001 |
Annualized Costs ($US/person) | 709 (420 - 1171) | 340 (191 - 636) | Â |
Annualized Number of | 109.8 ± 51.3 | 63.8 ± 45.4 | <0.001 |
Prescriptions/person | 104.1 (72.4 - 139.2) | 53.0 (30.0 - 93.6) | Â |